Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
IP3R/Ca2+/STAT3 Pathway in Nanoplastics and Cadmium Induced
2026-06-10
This study demonstrates that co-exposure to polystyrene nanoplastics and cadmium synergistically induces apoptosis in intestinal cells via the IP3R/Ca2+/STAT3 signaling axis. The findings clarify a key molecular mechanism underlying environmental co-toxicity, with direct implications for apoptosis research and calcium signaling modulation.
-
DiscoveryProbe Protease Inhibitor Library: HTS Workflows & I
2026-06-09
The DiscoveryProbe™ Protease Inhibitor Library empowers researchers to dissect protease-driven pathways in cancer, apoptosis, and infectious disease through validated, automation-ready screening. Explore optimized protocols, troubleshooting strategies, and next-generation applications anchored in recent mechanistic breakthroughs.
-
Cholesterol as the Principal Sterol in Lipid Nanoparticle Re
2026-06-09
Cholesterol is pivotal for engineering lipid nanoparticles that drive next-generation mRNA delivery in cancer research. This article translates recent breakthroughs in intravesical p21 mRNA–LNP therapy into actionable protocols and troubleshooting insights, leveraging the reproducibility of APExBIO’s high-purity cholesterol.
-
Nebivolol Hydrochloride in β1-Adrenoceptor Antagonist Resear
2026-06-08
Nebivolol hydrochloride delivers unmatched selectivity for β1-adrenoceptor antagonist studies, enabling precise dissection of cardiovascular signaling pathways. This article details optimized protocols, troubleshooting insights, and critical interpretation strategies to maximize data quality and experimental reproducibility in cardiovascular pharmacology research.
-
Q-VD-OPh: Pan-Caspase Inhibitor Empowering Apoptosis Researc
2026-06-08
Q-VD-OPh is a selective, irreversible pan-caspase inhibitor that transforms apoptosis research and cell viability workflows in both in vitro and in vivo settings. Its robust inhibition profile and brain permeability make it indispensable for dissecting caspase-driven mechanisms, optimizing advanced microscopy assays, and improving post-cryopreservation recovery.
-
Dantrolene Sodium Salt: Precision RyR Antagonism in DNA Repa
2026-06-07
Explore how Dantrolene sodium salt, a potent ryanodine receptor antagonist, enables advanced modulation of calcium signaling for DNA repair studies. This article provides a deep dive into its mechanism, implications for CRISPR pathway choice, and practical protocol guidance for translational research.
-
CB-5083 (SKU B6032): Reliable p97 Inhibition for Protein Hom
2026-06-06
This article delivers a scenario-driven, evidence-based exploration of CB-5083 (SKU B6032) as a potent, selective p97 inhibitor for laboratory research involving protein homeostasis disruption, cancer cell apoptosis induction, and tumor growth assays. Bench scientists will gain practical guidance on experimental design, assay optimization, and vendor reliability, with an emphasis on reproducibility and quantitative performance. The utility of CB-5083 is illustrated through real-world laboratory scenarios and supported by current literature.
-
CXCR4-Targeted Theranostics: Imaging and Therapy in Lymphoma
2026-06-05
The reference review details how CXCR4-targeted imaging ligands and antagonists enable precise diagnosis and therapy in lymphoma. By mapping the role of CXCR4 in tumor microenvironment interactions and resistance mechanisms, the study highlights key advances in molecular imaging, therapeutic strategies, and future directions for integrating these tools into precision oncology.
-
AMG 9810: Advanced Insights into TRPV1 Antagonist Mechanisms
2026-06-05
Explore AMG 9810 as a potent TRPV1 antagonist with unique mechanistic depth. This article examines its role in sensory neuron research and bridges emerging metabolic stress pathways for next-generation assay design.
-
Low-Affinity Blockade of N-Type Ca Channels by v-Agatoxin-IV
2026-06-04
Sidach and Mintz’s study reveals that v-Agatoxin-IVA, previously considered a highly selective P-type calcium channel blocker, also inhibits N-type channels at low affinity. This finding refines our understanding of calcium channel pharmacology and informs experimental strategies for dissecting neuronal calcium signaling.
-
Applied Use of AMG 9810 as a TRPV1 Antagonist in Pain Resear
2026-06-04
AMG 9810 is a potent TRPV1 antagonist uniquely suited for dissecting pain and sensory signaling mechanisms in vitro and in vivo. This article details best-practice experimental workflows, troubleshooting strategies, and how AMG 9810 can clarify complex signal transduction, leveraging recent insights into metabolic and oxidative stress adaptation.
-
Necroptosis-Driven Interferon Immunity Enhances Tumor Protec
2026-06-03
This study demonstrates that necroptosis, distinct from apoptosis, robustly stimulates type I interferon-mediated anti-tumor immunity, primarily via CD4+ T cells. The findings clarify the immunogenic mechanisms of necroptotic cell death and inform the design of advanced tumor immunization strategies.
-
BHQ and SERCA Inhibition: Advancing HSC Mobilization Science
2026-06-03
Explore how 2,5-di-tert-butylbenzene-1,4-diol (BHQ), a selective SERCA inhibitor, is redefining the landscape of hematopoietic stem cell (HSC) mobilization and calcium signaling research. This thought-leadership article delivers mechanistic insights, strategic guidance for translational workflows, and a forward-looking perspective on clinical impact—grounded in cutting-edge evidence and workflow integration.
-
Rosiglitazone (Brl-49653): Precision PPARγ Agonism in Metabo
2026-06-02
Rosiglitazone (Brl-49653) offers unmatched reliability as a PPARγ agonist for dissecting adipogenesis, insulin sensitivity modulation, and rare metabolic syndromes. Recent breakthroughs demonstrate its utility in rescuing functional deficits from pathogenic PPARG variants, setting a new benchmark for translational and mechanistic metabolic research.
-
5-Methyl-CTP: Enabling Next-Gen mRNA Vaccine Engineering
2026-06-02
Discover how 5-Methyl-CTP empowers mRNA synthesis with enhanced stability and translation efficiency. This in-depth guide explores its pivotal role in advanced vaccine engineering, with practical insights and evidence from recent landmark research.